Clinical trialNCT02951026CompletedObservational

An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis

SponsorBiosplice Therapeutics, Inc.Enrollment703Osteoarthritis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Yusuf Yazici, M.D.
Biosplice Therapeutics, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

62 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Birmingham, Alabama, United States
Research Site
Oro Valley, Arizona, United States
Research Site
Phoenix, Arizona, United States
Research Site
Tucson, Arizona, United States
Research Site
Canoga Park, California, United States
Research Site
Carmichael, California, United States
Research Site
Cerritos, California, United States
Research Site
El Cajon, California, United States
Research Site
Gold River, California, United States
Research Site
La Mesa, California, United States
Research Site
Palm Springs, California, United States
Research Site
Rancho Mirage, California, United States
Research Site
Sacramento, California, United States
Research Site
San Diego, California, United States
Research Site
San Marcos, California, United States
Research Site
Spring Valley, California, United States
Research Site
Boulder, Colorado, United States
Research Site
Stamford, Connecticut, United States
Research Site
Trumbull, Connecticut, United States
Research Site
Waterbury, Connecticut, United States
Research Site
Clearwater, Florida, United States
Research Site
Coral Gables, Florida, United States
Research Site
DeLand, Florida, United States
Research Site
Edgewater, Florida, United States
Research Site
Lauderdale Lakes, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Marietta, Georgia, United States
Research Site
Woodstock, Georgia, United States
Research Site
Chicago, Illinois, United States
Research Site
Newton, Kansas, United States
Research Site
Wichita, Kansas, United States
Research Site
Lexington, Kentucky, United States
Research Site
Frederick, Maryland, United States
Research Site
Boston, Massachusetts, United States
Research Site
Troy, Michigan, United States
Research Site
City of Saint Peters, Missouri, United States
Research Site
Kansas City, Missouri, United States
Research Site
St Louis, Missouri, United States
Research Site
Lincoln, Nebraska, United States
Research Site
Las Vegas, Nevada, United States

22 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Sept 2016
Primary completion: 31 Oct 2019
Completion: 31 Oct 2019
Last update posted: 17 Apr 2020
Registered enrollment: 703
Registry id: NCT02951026

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.